Chiral Amino Diol Derivatives as New Modular Organocatalysts
9.2 Hz, J=8.0 Hz, 1H), 5.10 (sept, J=6.4 Hz, 1H);
13C NMR (100 MHz, CDCl3): d=19.1, 21.4, 21.6, 35.4, 38.3,
69.8, 71.1, 166.7, 206.2.
tert-Butyl 1-chloro-2-oxocyclopentanecarboxylate (3d):
Yellowish solid, known compound.[12] GC conditions: Chiral-
dexꢇ G-TA; T1 =508C, t1 =1 min, v1 =88CminÀ1, T2 =
1358C, t2 =25 min, v2 =108CminÀ1, T3 =508C, t3 =1 min;
tR =23.4 [major], tR =23.7 [minor].
2H), 3.16–3.24 (m, 1H), 3.83 (s, 3H), 3.85 (s, 3H), 7.12 (dd,
J=8.4 Hz, J=2.8 Hz, 1H), 7.18 (d, J=8.4 Hz, 1H), 7.54 (d,
J=2.8 Hz, 1H); 13C NMR (100 MHz, CDCl3): d=24.8, 35.3,
53.8, 55.5, 70.7, 110.5, 123.1, 130.0, 130.3, 135.2, 158.7, 168.0,
187.5.
Methyl
2-chloro-7-bromo-1-oxo-1,2,3,4-tetrahydronaph-
thalene-2-carboxylate (3n): White solid, HPLC conditions:
Daicel Chiralpakꢇ AD-H; hexane/IPA (98/2), 1.0 mLminÀ1,
254 nm; tR =12.2 [major], tR =13.0 [minor]. 1H NMR
(400 MHz, CDCl3): d=2.50–2.55 (m, 1H), 2.93–3.09 (m,
2H), 3.17–3.25 (m, 1H), 3.85 (s, 3H), 7.17 (d, J=8.4 Hz,
1H), 7.64 (dd, J=2.0 Hz, J=8.4 Hz, 1H), 8.19 (bs, 1H),
13C NMR (100 MHz, CDCl3): d=25.1, 29.7, 34.8, 53.9, 70.2,
121.2, 130.5, 131.0, 131.5, 137.2, 141.2, 167.6, 186.3.
Benzyl
1-chloro-2-oxocyclopentanecarboxylate
(3e):
HPLC conditions: Daicel Chiralpakꢇ IB; hexane/IPA (99.2/
0.8), 1.0 mLminÀ1, 220 nm); tR =16.3 [minor], tR =17.1
1
[major]. H NMR (400 MHz, CDCl3): d=1.96–2.13 (m, 2H),
2.26–2.35 (m, 2H), 2.44–2.53 (m, 1H), 2.67 (ddd, J=
14.4 Hz, J=9.6 Hz, J=7.2 Hz, 1H), 5.16 (d, J=12.2 Hz,
1H), 5.20 (d, J=12.2 Hz, 1H), 7.25–7.30 (m, 5H); 13C NMR
(100 MHz, CDCl3): d=19.1, 35.3, 38.3, 66.2, 68.5, 128.0,
128.5, 128.6, 134.7, 167.1, 205.9.
Methyl 2-chloro-1-oxo-2,3-dihydro-1H-indene-2-carboxyl-
ate (3f): Pale yellow solid, known compound.[12] HPLC con-
ditions: Daicel Chiralpakꢇ IB; hexane/IPA (97/3),
1.0 mLminÀ1, 245 nm); tR =9.8 [major], tR =11.0 [minor].
Isopropyl 2-chloro-1-oxo-2,3-dihydro-1H-indene-2-carbox-
ylate (3g): Colourless oil, known compound.[12] HPLC condi-
tions: Daicel Chiralpakꢇ IB; hexane/IPA (99/1),
0.8 mLminÀ1, 245 nm); tR =10.4 [major], tR =11.3 [minor].
Methyl 1-chloro-2-oxocyclohexanecarboxylate (3h): Col-
ourless oil, GC conditions: Chiraldexꢇ G-TA; T1 =508C,
t1 =1 min, v1 =88CminÀ1, T2 =1508C, t2 =15 min, v2 =
108CminÀ1, T3 =508C, t3 =1 min; tR =22.0 [minor], tR =25.3
Acknowledgements
The financial support of the Spanish Ministry of Science and
Innovation and European Regional Development Fund
(CTQ2008-00187/BQU) and the Government of Aragꢀn
(GA E-71) is acknowledged.
References
[1] a) H. House, Modern Synthetic Reactions, 2nd edn.,
W. A. Benjamin, New York, 1972, pp 459–478; b) N.
De Kimpe, R. Verhꢂ, The Chemistry of a-Haloketones,
a-Haloaldehydes, and a-Haloimines, John Wiley &
Sons, New York, 1988; c) R. C. Larock, Comprehensive
Organic Transformations, 2nd edn., Wiley-VCH, New
York, 1999; d) G. Thomas, Medicinal Chemistry: An In-
troduction, Wiley, New York, 2000.
[2] C. Czekelius, C. C. Tzschucke, Synthesis 2010, 543–566.
[3] For recent reviews on enantioselective halogenation re-
actions see: a) J. A. Ma, D. Cahard, Chem. Rev. 2004,
104, 6119–6146; b) H. Ibrahim, A. Togni, Chem.
Commun. 2004, 1147–1155; c) S. France, A. Weather-
wax, T. Lectka, Eur. J. Org. Chem. 2005, 475–479;
d) M. Oestreich, Angew. Chem. 2005, 117, 2376–2379;
Angew. Chem. Int. Ed. 2005, 44, 2324–2327; e) G. K. S.
Prakash, P. Beier, Angew. Chem. 2006, 118, 2228–2230;
Angew. Chem. Int. Ed. 2006, 45, 2172–2174; f) C.
Bobbio, V. Gouverneur, Org. Biomol. Chem. 2006, 4,
2065–2075; g) N. Shibata, T. Ishimaru, S. Nakamura, T.
Toru, J. Fluorine Chem. 2007, 128, 469–483; h) V. A.
Brunet, D. OꢅHagan, Angew. Chem. 2008, 120, 1198–
1201; Angew. Chem. Int. Ed. 2008, 47, 1179–1182; i) K.
MuÇiz, Top. Organomet. Chem. 2010, 31, 1–18.
1
[major]. H NMR (400 MHz, CDCl3): d=1.65–1.78 (m, 1H),
1.85–2.00 (m, 3H), 2.14 (ddd, J=14.0 Hz, J=8.0 Hz, J=
3.2 Hz, 1H), 2.41 (ddd, J=13.7 Hz, J=6.6 Hz, J=6.6 Hz,
1H), 2.73–2.89 (m, 2H), 3.82 (s, 3H); 13C NMR (100 MHz,
CDCl3): d=21.9, 26.6, 38.6, 39.5, 53.6, 73.3, 166.7, 199.6.
Ethyl 1-chloro-2-oxocyclohexanecarboxylate (3i): Colour-
less oil, known compound.[6] GC conditions: Chiraldexꢇ G-
TA ; T1 =508C, t1 =1 min, v1 =88CminÀ1, T2 =1508C, t2 =
15 min, v2 =108CminÀ1, T3 =508C, t3 =1 min; tR =22.4
[minor], tR =26.0 [major].
Isopropyl 1-chloro-2-oxocyclohexanecarboxylate (3j): Col-
ourless oil, GC conditions: Chiraldexꢇ G-TA; T1 =508C,
t1 =1 min, v1 =88CminÀ1, T2 =1508C, t2 =15 min, v2 =
108CminÀ1, T3 =508C, t3 =1 min; tR =21.0 [minor], tR =23.9
1
[major]. H NMR (400 MHz, CDCl3): d=1.28 (d, J=6.4 Hz,
6H), 1.68–1.77 (m, 1H), 1.78–2.00 (m, 3H), 2.05–2.13 (m,
1H), 2.42 (ddd, J=14.0 Hz, J=9.2 Hz, J=5.2 Hz, 1H),
2.76–2.86 (m, 2H), 5.11 (sept, J=6.4 Hz, 1H); 13C NMR
(100 MHz, CDCl3): d=21.3, 21,4, 22,3, 26.7, 39.0, 39.7, 70.0,
73.7, 166.6, 199.6.
Methyl
2-chloro-1-oxo-1,2,3,4-tetrahydronaphthalene-2-
carboxylate (3k): Pale yellow oil, known compound.[12]
HPLC conditions: Daicel Chiralpakꢇ IB; hexane/IPA (98/2),
1.0 mLminÀ1, 245 nm; tR =10.7 [mayor], tR =12.3 [minor].
Isopropyl 2-chloro-1-oxo-1,2,3,4-tetrahydronaphthalene-2-
carboxylate (3l): Colourless oil, known compound.[12] HPLC
conditions: Daicel Chiralpakꢇ IA; hexane/IPA (99/1),
0.8 mLminÀ1, 245 nm; tR =11.3 [minor], tR =12.5 [major].
Methyl 2-chloro-7-methoxy-1-oxo-1,2,3,4-tetrahydronaph-
thalene-2-carboxylate (3m): White solid. HPLC conditions:
Daicel Chiralcelꢇ OD-H; hexane/IPA (98/2), 1.0 mLminÀ1,
254 nm; tR =19.9 [major], tR =21.8 [minor]. 1H NMR
(400 MHz, CDCl3): d=2.48–2.54 (m, 1H), 2.91–3.00 (m,
[4] For recent reviews on organocatalysis in enantioselec-
tive halogenation reactions see: a) G. Guillena, D. J.
Ramꢀn, Tetrahedron: Asymmetry 2006, 17, 1465–1492;
b) M. Marigo, K. A. Jørgensen, Chem. Commun. 2006,
2001–2011; c) P. M. Pihko, Angew. Chem. 2006, 118,
558–561; Angew. Chem. Int. Ed. 2006, 45, 544–547;
d) M. Ueda, T. Kano, K. Maruoka, Org. Biomol. Chem.
2009, 7, 2005–2012.
[5] For organocatalytic a-chlorination of ketones see: M.
Marigo, S. Bachmann, N. Halland, A. Braunton, K. A.
Adv. Synth. Catal. 2010, 352, 3329 – 3338
ꢆ 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
3337